Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions
- PMID: 25635489
- DOI: 10.1164/rccm.201411-2044ED
Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
